N‐Acetylcysteine–Mediated Surface Remodeling of Inhaled mRNA Lipid Nanoparticles Enables Coordinated Mucosal and Systemic Antitumor Immunity
Advanced Materials · 2026-09 · 38 (54)
DOI: 10.1002/adma.73362 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Materials, online erschienen am 13.05.2026. Verfasst von Xingdi Cheng und 13 weiteren Autor:innen. Beteiligte Einrichtung: Beijing National Laboratory for Molecular Sciences, CAS Key Laboratory of Colloid, Interface and Chemical Thermodynamics, Institute of Chemistry, Chi…. Hauptthemen laut MEDLINE: RNA, Messenger, Nanoparticles, Acetylcysteine, Lipids. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 57 Literaturangaben. Gefördert von: National Key Research and Development Program of China, Strategic Priority Research Program of the Chinese Academy of Sciences, National Natural Science Foundation of China.
Abstract (Originalsprache)
Inhaled messenger RNA (mRNA) delivery is constrained by aerosolization‐induced stress and airway barriers that limit post‐deposition transport and immune activation. Here, we report an N‐acetylcysteine (NAC)—enabled strategy that dynamically remodels inhaled mRNA lipid nanoparticles (LNP) after airway deposition. The LNPs are stabilized through electrostatic repulsions during nebulization by a negatively charged, disulfide‐linked peptide–lipid conjugate on the LNP surface. Following deposition, NAC mediates thiol–disulfide exchange to cleave the peptide–lipid linkage, removing the anionic peptide and restoring cellular uptake while preserving aerosol stability. Concurrently, NAC reduces mucus density as a mucolytic, enhancing LNP penetration and trans‐epithelial transport. As a result, inhaled mRNA‐LNP yields robust pulmonary mRNA expression and enables mRNA expression in extrapulmonary tissues. Immunologically, inhaled mRNA‐LNPs elicit strong mucosal immune responses, while NAC‐enabled delivery additionally activates systemic immune activation. In mouse tumor models, this strategy achieves complete eradication of distant tumors and confers durable protection against tumor rechallenge. These findings highlight the potential of dynamic nanoparticle surface remodeling to overcome barriers in inhaled mRNA delivery.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Beijing National Laboratory for Molecular Sciences, CAS Key Laboratory of Colloid, Interface and Chemical Thermodynamics, Institute of Chemistry, Chinese Academy of Sciences, Beijing, China.
- University of Chinese Academy of Sciences, Beijing, China.
- Laboratory Animal Center of Institute of Biophysics, Chinese Academy of Sciences, Beijing, China.
- Aviation General Hospital of Beijing, Beijing, China.
- Department of Lung Cancer Center and Center for Preclinical Safety Evaluation of Drugs, West China Hospital, Sichuan University, Chengdu, China.
ORCID-Profile: Xueguang Lu
Förderung
- National Key Research and Development Program of China
- Strategic Priority Research Program of the Chinese Academy of Sciences
- National Natural Science Foundation of China
- International Partnership Program of the Chinese Academy of Sciences
Zitieren
APA
Cheng, X., Li, Q., Zu, H., Liu, S., Li, J., Wen, Y., Yang, C., Sun, S., Lu, H., Zhang, Y., Zhao, Y., Shi, G., Qin, M., & Lu, X. (2026). N‐Acetylcysteine–Mediated Surface Remodeling of Inhaled mRNA Lipid Nanoparticles Enables Coordinated Mucosal and Systemic Antitumor Immunity. Advanced Materials, 38(54). https://doi.org/10.1002/adma.73362
Vancouver
Cheng X, Li Q, Zu H, Liu S, Li J, Wen Y, et al. N‐Acetylcysteine–Mediated Surface Remodeling of Inhaled mRNA Lipid Nanoparticles Enables Coordinated Mucosal and Systemic Antitumor Immunity. Advanced Materials. 2026;38(54). doi:10.1002/adma.73362
BibTeX
@article{Cheng2026,
author = {Cheng, Xingdi and Li, Qing and Zu, Haowei and Liu, Shuai and Li, Jingjiao and Wen, Yixing and Yang, Chen and Sun, Simin and Lu, Haoyu and Zhang, Yuzhou and Zhao, Yumeng and Shi, Guizhi and Qin, Meng and Lu, Xueguang},
title = {N‐Acetylcysteine–Mediated Surface Remodeling of Inhaled mRNA Lipid Nanoparticles Enables Coordinated Mucosal and Systemic Antitumor Immunity},
journal = {Advanced Materials},
year = {2026},
volume = {38},
number = {54},
doi = {10.1002/adma.73362}
}
EUVIMED